InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Juda Scott, Director. Officer active across 1 company, notably Inmune Bio, Inc.. In total, 6 disclosures have been logged. Split: 4 buys · 0 sell. Total volume traded: €341k. Activity tracked since 17 November 2021. The latest transaction was filed on 2 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Scott Juda is a Director at Inmune Bio, Inc. In this role, he participates in strategic decision-making and governance of the company. His experience in the biotechnology sector allows him to provide valuable insights to the board.